Jonathan Bush has three rules he thinks digital health startups should follow as the country prepares for a likely recession. They should ensure their technology accomplishes a task that healthcare stakeholders need fulfilled, be very clear about how they can make more money doing their job than their competitors, and find "people who are unhinged enough" to try their product.
Check out new developments from Carrum Health, Springboard Enterprises, Bessemer Venture Partners, and more.
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
In this episode of the MedCity Pivot Podcast, Jonathan Bush talks about his latest venture - Zus Health - through which he wants to help digital health companies share data to create a universal patient off of which new products can be created to serve payers, providers and others with the ultimate goal of improving patient outcomes.
"My experience is running a company with a gun to your head is no way to run a company. Better to just say, 'Pull the trigger,'" Bush said when asked about having an activist investor like Elliott take a stake in his company.
Meanwhile, the Watertown, Massachusetts EHR vendor has extended the deadline for a final buyout bid to September 27.
Reporters have been aware of athenahealth CEO's flamboyant self, crazy parties, and company conferences and in a way bear some responsibility for ignoring any alleged inappropriate behavior.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Bush's departure comes after he admitted to physically attacking his ex-wife and as allegations of his inappropriate behavior at athenahealth were brought into the spotlight.
In a letter to athenahealth's board of directors, Elliott Management Partner Jesse Cohn makes his firm's case for why the company would be better off as a private business.
Though Q4 and full-year revenue for the Watertown, Massachusetts-based company were up, bookings dropped. CEO Jonathan Bush contributed this to the healthcare industry currently being in a "sugar low."
In the past, term sheets for athenahealth's More Disruption Please accelerator have invited some scrutiny. This time we ask the cloud-based EHR company's CEO for comment.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Healthcare just won't stop colliding with pop culture, will it? In the wake of news about a Martin Shkreli musical, we also learn that athenahealth boss Jonathan Bush has responded to John Oliver.
Ever feel overmatched? That's how our reporter felt at HIMSS16 in Las Vegas last week when he did a video — streamed live online by HealthIT.TV — with athenahealth CEO Jonathan Bush and Dr. Zubin "ZDoggMD" Damania.
Jonathan Bush got some love at HIStalk's HISsie awards last night.
The Office of the Chief Medical Examiner declined to give a cause of death pending the outcome of additional tests.
Here are three things that were absent from the J.P. Morgan 2016 Healthcare Conference in San Francisco last week.